Back

Anti-thymocyte globulin induction therapy usage is not associated with short and long-term survival differences in heart transplant patients

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiovascular Surgery - Transplantation Transplantation HFA Premium Access Heart Failure 2019

About the speaker

Photo
Mr Sangyang Jia

London Health Sciences Centre, London (Canada)

4 More presentations in this session

Presentation thumbnail
Doctor E. Bobbio (Gothenburg, SE)
Abstract
Presentation thumbnail
Doctor R. Lopez Vilella (Valencia, ES)
Abstract
Presentation thumbnail
Doctor R. Lopez Vilella (Valencia, ES)
Abstract
Presentation thumbnail
Mr S. Jia (London, CA)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Cardiovascular Surgery - Transplantation

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of induction therapy on the risk of mortality in direct ECMO-bridged heart transplantation
15 March 2025
thumbnail
Congress Session
Challenges and opportunities in heart transplantation and ventricular assist devices
25 August 2023
thumbnail
Congress Presentation
Contemporary use of iSGLT2 in heart transplant patients: indications and safety
20 May 2023
thumbnail
Congress Presentation
Survival after heart transplantation: the role of psychosocial variables and patients' expectations toward themselves and others
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources